BLLPC - E SERIES ULTRAJET, ES1275
- MSDS: BLLPC
- Manufacturer: CHEMTRONICS
- Product Name: E SERIES ULTRAJET, ES1275
- National Stock Number: 6830-00N021051
Product Identification
Product ID:E SERIES ULTRAJET, ES1275
MSDS Date:01/01/1989
FSC:6830
NIIN:00N021051
MSDS Number: BLLPC
Responsible Party
HAUPPAUGE, NY 11788
US
Emergency Phone: 516-582-3322
Info Phone: 516-582-3322
Cage: 21267
Contractor
Telephone: 770-424-4888/800-645-5244
Cage: 21267
Ingredients
EPINEPHRINE)MAY BE CONTRAINDICATED EXCEPT FOR
RTECS: 9999999ZZ
BE CONSIDERED ONLY AS A LAST RESORT IN LIFE
RTECS: 9999999ZZ
CHLORODIFLUOROMETHANE
CAS: 75-45-6
RTECS: PA6390000
Fraction By Weight: 100%
OSHA PEL 1000 PPM
ACGIH TLV: 1000PPM; 9192
FLUORIDES AND/OR PHOSGENE .
RTECS: 9999999ZZ
RELEASED. MECHANICAL VENTILATION SHOULD BE USED IN
RTECS: 9999999ZZ
Hazards
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHAL:VAP IS HVR/AIR & CAN CAUSE
SUFFOCATION BY REDUCING OXYGEN AVAIL FOR BRTHG. BRTHG HIGH CONC OF
PROD CAN CAUSE LIGHT-HEADEDNESS, GIDD, SHORTNESS OF BREATH, POSS
NARCOSIS, POSS CARDIAC IRREGULARITI ES, UNCON/DEATH. EYE:LIQ CONT
CAN CAUSEFROSTBITE. SKIN:LIQ CONT CAN CAUSE FROSTBITE. NOTE:IN (SEE
EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ:SCREENING STUDIES W/EXPERIMENTAL
ANIMALS, EXPOS AT APPROX 50,000 PPM (V/V) & ABOVE, FOLLOWED BY LRG
INTRAVENOUS EPINEPHRINE CHALLENGE, HAS INDUCED SERIOUS CARDIAC
IRREGULARITIES. IN CHRONIC I NHAL STUDIES, HAS PRODUCED SM
INCIDENCEOF TUMORS IN MALE RATS, BUT NOT FEMALE RATS/MICE AT A CONC
OF 50,000 (SUPP DATA)
Medical Cond Aggravated by Exposure:CARDIOVASCULAR DISEASE; SEE
PRINCIPAL HEALTH HAZARDS, INHALATION SECTION.
First Aid
First Aid:INHAL:REMOVE TO FRESH AIR. CALL MD. IF NOT BRTHG GIVE ARTF
RESP, PREF MOUTH-TO-MOUTH. IF BRTHG DFCLT, GIVE OXYGEN. DO NOT GIVE
EPINEPHRINE OR SIMILAR DRUGS. EYE: FLUSH WITH WATER FOR AT LEAST 15
MIN. CALL MD. SKIN: FLUSH WITH WATER. TREAT FOR FROSTBITE IF
NECESSARY. NOTE TO MD: BECAUSE OF POSS INCR RISK OF ELICITING
CARDIAC DYSRYTHMIAS, CATECHOLAMINE DRUGS, SUCH AS EPINEPHRINE,
SHOULD (SEE ING 5)
Fire Fighting
Flash Point Method:TOC
Flash Point:NONFLAMMABLE
Lower Limits:NONFLAMMABLE
Upper Limits:NONFLAMMABLE
Extinguishing Media:NONFLAMMABLE. USE MEDIA SUITABLE FOR SURROUNDING
FIRE .
Fire Fighting Procedures:WEAR NIOSH/MSHA APPRVD PRESS DMD SCBA & FULL
PROT EQUIP . OTHER BURNING MATL MAY CAUSE ULTRAJET TO BURN WEAKLY.
EXTING FOR OTHER BURNING MATL (SUPP DATA)
Unusual Fire/Explosion Hazard:CYL ARE EQUIPPED W/PRESS RELIEF DEVICES
BUT STILL MAY RUPT UNDER FIRE CNDTNS.DECOMP MAY OCCUR.THERM DECOMP
PRODS MAY INCL FLUORIDES, CHLORIDES & PHOSGENE.
Accidental Release
Spill Release Procedures:VENTILATE AREA - ESPECIALLY LOW PLACES WHERE
HEAVY VAPORS MIGHT COLLECT. REMOVE OPEN FLAMES.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
Handling
Handling and Storage Precautions:CLEAN, DRY AREA. DO NOT HEAT ABOVE
100F. DO NOT PUNCTURE OR DAMAGE CONTAINERS. ROTATE STOCK.
Other Precautions:AVOID BRTHG VAPS & LIQ CONT W/SKIN/EYES.DO NOT TURN
AEROSOL CAN UPSIDE DOWN WHEN SPRAYING.NO SMOKING IN AREA OF USE.DO
NOT USE IN GEN VICINITY OF ARC WELD/OPEN FLAMES/HOT SURF.HEAT
AND/OR UV RAD MAY C AUSE FORMATION OF CHLORIDES, (SEE ING 2)
Exposure Controls
Respiratory Protection:UNDER NORMAL MANUFACTURING CONDITIONS, NO
RESPIRATORY PROTECTION IS REQUIRED WHEN USING THIS PRODUCT.
NIOSH/MSHA APPROVED SCBA IS REQUIRED IF A LARGE RELEASE OCCURS.
Ventilation:NORMAL VENT FOR STANDARD MFR PROCEDURES IS GENERALLY ADEQ.
LOCAL EXHST SHOULD BE USED WHEN LRG AMTS ARE (SEE ING 3)
Protective Gloves:LINED BUTYL GLOVES.
Eye Protection:CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:NONE SPECIFIED BY MANUFACTURER.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
FIRE FIGHT PROC:IN AREA IS SUFF TO STOP BURNING.HAZ DECOMP
PRODS:ACIDS-POSS CARBONYL HALIDES.CHLORIDES/FLUORIDES/ PHOSGENE
.EFTS OF OVEREXP:PPM (V/V).CHLOROFLUOROCARBON (CFC) MATLS HAVE
PRODUCED SENSIT OF MYOCARDIUM TO EPINEPHRINE INLAB ANIMALS & COULD
HAVE A SIMILAR EFT IN HUMANS.ADRENOMIMETICS (E.G.(SEE ING 4)
Chemical Properties
HCC:G3
Boiling Pt:B.P. Text:-41F,-41C
Vapor Pres:138 PSIG
Vapor Density:2.98
Solubility in Water:0.30% BY WT @ 77F
Appearance and Odor:CLEAR, COLORLESS LIQUIFIED GAS WITH A SLIGHT
ETHERAL ODOR.
Percent Volatiles by Volume:100
Stability
Stability Indicator/Materials to Avoid:YES
ALKALI OR ALKALINE EARTH METALS-POWERED AL, ZN, BE, ETC.
Stability Condition to Avoid:AVOID OPEN FLAMES AND HIGH TEMPERATURES.
Hazardous Decomposition Products:ULTRAJET CAN BE DECOMPOSED BY HIGH
TEMPS (OPEN FLAMES, GLOWING METAL SURF, ETC) FORMING HCL &
HYDROFLUORIC (SUPP DATA)
Disposal
Waste Disposal Methods:ALLOW TO EVAPORATE. DO NOT PUNCTURE OR
INCINERATE AEROSOL CANS. COMPLY WITH FEDERAL, STATE AND LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.